Marc Masa is a biologist specializing in preclinical oncology, with more than 25 years of research experience in the private sector, including the pharmaceutical industry. His work focuses on drug and biomarker discovery in oncology. He is a co-author of several patents and has published scientific articles in leading journals. He has also undertaken numerous research projects. He is currently the director of the Department of Health and Biomedicine at Leitat.